/PRNewswire/ - Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing the first once-daily therapeutic to prevent.
– Proceeds to Advance Breakthrough Drug Stabilization Technology Enabling Thermostable and Concentrated Formulation of Biologics –– Financing Co-Led by Breakout Ventures and the Perceptive Xontogeny Venture Fund –PALO ALTO, Calif. (BUSINESS WIRE) Surf Bio, Inc., a biopharmaceutical company commercializing a novel.
Avenge Bio Appoints Douglas Carlson as Chief Operating and Financial Officer - read this article along with other careers information, tips and advice on BioSpace
Ceptur Therapeutics Launches with $75 Million to Advance Novel RNA Therapeutics globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.